HCA Healthcare, Inc. $HCA Stake Lessened by State of Alaska Department of Revenue

Key Points

• The State of Alaska Department of Revenue reduced its stake in HCA Healthcare by 7.3% in the second quarter, resulting in ownership of 19,425 shares valued at approximately $7.44 million.
• HCA Healthcare's recent quarterly earnings report showed an EPS of $6.84, surpassing estimates, with revenue of $18.61 billion, representing a 6.4% year-over-year increase.
• The company has announced a quarterly dividend of $0.72 per share, with an annualized yield of 0.7% to be paid on September 30th.

State of Alaska Department of Revenue lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 7.3% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 19,425 shares of the company's stock after selling 1,530 shares during the period. State of Alaska Department of Revenue's holdings in HCA Healthcare were worth $7,441,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of HCA Healthcare by 11.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company's stock valued at $8,796,000 after acquiring an additional 2,698 shares during the period. Brown Advisory Inc. increased its position in shares of HCA Healthcare by 53.9% in the first quarter. Brown Advisory Inc. now owns 4,630 shares of the company's stock worth $1,600,000 after purchasing an additional 1,622 shares during the period. Harrell Investment Partners LLC raised its position in HCA Healthcare by 176.3% in the second quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company's stock valued at $695,000 after purchasing an additional 1,158 shares during the last quarter. Farther Finance Advisors LLC raised its position in shares of HCA Healthcare by 26.9% in the 1st quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company's stock worth $395,000 after acquiring an additional 242 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. lifted its stake in shares of HCA Healthcare by 2.5% in the first quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company's stock valued at $1,491,000 after buying an additional 105 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $419.77 on Friday. The firm's 50-day simple moving average is $389.80 and its 200-day simple moving average is $369.17. The firm has a market cap of $98.22 billion, a PE ratio of 17.64, a price-to-earnings-growth ratio of 1.32 and a beta of 1.41. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $422.46.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business's revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the firm posted $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's payout ratio is 12.11%.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on HCA shares. Barclays upped their price objective on shares of HCA Healthcare from $390.00 to $445.00 and gave the stock an "overweight" rating in a research report on Thursday, September 18th. Robert W. Baird raised their price target on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a report on Thursday, August 14th. Bank of America raised their price target on shares of HCA Healthcare from $375.00 to $410.00 and gave the stock a "neutral" rating in a research note on Wednesday, September 10th. Wolfe Research cut shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. Finally, Truist Financial lifted their price target on HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research note on Wednesday, July 16th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $407.75.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares of the company's stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.